Search
forResearch 10 of 1000+
- Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence
- Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease
- Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Premature graying of hair: Risk factors, co‐morbid conditions, pharmacotherapy and reversal—A systematic review and meta‐analysis
- Bound on the Risk for M-SVMs
Community 10 of 86
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- A warning to those thinking about using Dutasteride
- Nutrafol backed by Science to reverse male balding?
- Thoughts about ORAL ketoconazole? (pills)
- Aminexil. Where to get it?
- 18M 8 months progress 40mg daily dut stack
- Deciding Between Oral or Topical Min and Fin with Fatty Liver
- Increased liver enzymes from hairloss medications.
- Can liver problems be associated with response to the oral minoxidil?
- Sensitive liver, topical fin safe to try?